Browse the evidence

Intermittent administration of the senolytic drug combination dasatinib and quercetin (D&Q) reduces senescence and inflammation in adipose tissue, leading to improved systemic metabolic function (fasting glucose, glucose tolerance, and lipid profiles) in old age.

For older adults, intermittent treatment with dasatinib and quercetin may improve metabolic health by clearing senescent cells from fat tissue, reducing inflammation, and improving glucose tolerance. This suggests that targeting cellular aging could be a viable strategy for managing age-related metabolic decline.

Women do not experience the significant increase in muscle glycogen or performance time-to-fatigue that men experience in response to a high-carbohydrate loading diet (75% of energy).

If you are a female endurance athlete, simply increasing your carbohydrate intake to 75% of your calories for 4 days before an event may not increase your muscle glycogen or extend your time to fatigue as it does for men. Your body naturally relies more on fat oxidation during submaximal exercise, sparing glycogen. You may not need to carb-load as aggressively as male athletes to achieve similar metabolic efficiency, and forcing high carb intake might not provide the expected performance boost.

Fructose consumption promotes disease progression from simple steatosis to nonalcoholic steatohepatitis (NASH) by inducing oxidative stress, endoplasmic reticulum (ER) stress, and inflammation via mechanisms including uric acid production and methylglyoxal accumulation.

If you have fatty liver, reducing fructose is crucial not just for fat loss but to stop the inflammation and stress that turn simple fat accumulation into serious liver disease (NASH).

Chronic systemic inflammation drives skeletal muscle atrophy by directly activating pro-catabolic signaling pathways (NF-κB, JAK/STAT, p38MAPK) that increase protein degradation via UPS/ALP and inhibit protein synthesis via IGF-1/Akt/mTOR suppression.

If you are experiencing muscle loss alongside a chronic inflammatory condition (like autoimmune disease, diabetes, or chronic infection), standard resistance training and high protein intake may be insufficient on their own. Medical management of the underlying inflammation is critical to stop the biological signals that actively break down muscle tissue.

Inflammation indirectly causes muscle atrophy by dysregulating the Hypothalamic-Pituitary-Adrenal (HPA) axis, leading to excessive glucocorticoid release, which further inhibits muscle protein synthesis and promotes proteolysis.

Managing stress and underlying inflammation is crucial because chronic stress and inflammation can trigger hormonal responses (cortisol) that actively break down muscle. Medical interventions that stabilize the HPA axis or reduce inflammatory cytokines may help preserve muscle mass.

Myostatin (MSTN) levels are increased by inflammatory factors (TNF-α, IL-6) and act as a negative regulator of muscle mass by activating the Smad2/3 pathway, which upregulates E3 ubiquitin ligases (MuRF1, Atrogin-1) and inhibits satellite cell recruitment.

High levels of inflammatory cytokines can increase Myostatin, a protein that naturally limits muscle growth. In chronic disease, this system is overactive, contributing to muscle loss. Therapies targeting Myostatin or its receptors are being investigated to counteract this loss.

Obesity and type 2 diabetes are characterized by impaired insulin-stimulated PI3K activity and downstream signaling (specifically AS160 phosphorylation and PKCλ/ζ activation) in skeletal muscle, leading to defective GLUT4 translocation and insulin resistance.

In obesity and type 2 diabetes, your muscles' ability to respond to insulin is blunted because the internal signaling chain (PI3K, AS160, PKC) is disrupted, preventing glucose transporters from moving to the cell surface. This is a signaling defect, not necessarily a lack of transporters. Weight loss and specific medications (like TZDs) can help restore this signaling.

Higher body mass index (BMI > 25 kg/m²) is associated with a protective effect against hip fracture burden, reducing DALYs by up to 24.1% for BMI > 35 kg/m² compared to a BMI of 21.5–25 kg/m².

This study suggests that higher body weight (BMI > 25) may protect against hip fractures, likely due to mechanical cushioning. However, the authors explicitly state that recommending weight gain is inappropriate due to the association with other morbidities. Focus on maintaining a healthy weight through balanced nutrition and activity rather than targeting weight loss specifically for bone health.

Mechanical unloading (disuse) induces skeletal muscle atrophy primarily through a dual mechanism: suppression of the IGF-1-Akt-mTOR protein synthesis pathway and upregulation of the ubiquitin-proteasome system (specifically MuRF1/MAFbx E3 ligases) driven by FOXO transcription factors.

If you are experiencing forced inactivity (like casting or bed rest), your muscles will shrink due to suppressed growth signals (mTOR) and increased breakdown signals (FOXO/MuRF1). While you cannot fully stop this, engaging in any available resistance exercise (even isometric) or ensuring adequate protein intake may help mitigate the rate of loss by keeping these pathways partially active.

Oxidative stress (ROS overproduction) and Calcium (Ca2+) overload are major triggers that exacerbate disuse-induced muscle atrophy by promoting protein breakdown and inhibiting synthesis.

Managing oxidative stress and calcium handling may help protect muscle during periods of inactivity. Antioxidants and strategies to maintain muscle membrane integrity might be beneficial, though the paper notes these are 'potential countermeasures' requiring more research.

Short-term administration of high-dose intramuscular testosterone esters in older men (age >60) significantly worsens sleep architecture and breathing by reducing total sleep time and increasing respiratory disturbance indices and hypoxemia duration.

If you are an older man considering high-dose testosterone therapy, be aware that it can significantly reduce your total sleep time and worsen breathing during sleep (increasing apnea events). While this short-term high-dose study did not show immediate negative effects on physical or mental function, the sleep disruption is a significant safety concern that warrants monitoring, especially if you have risk factors for sleep apnea.

Activation of AMPK exerts anti-tumor effects by inhibiting mTORC1, promoting oxidative metabolism, and inducing cell cycle arrest, thereby opposing the Warburg effect.

Maintaining healthy cellular energy balance through lifestyle and potentially AMPK-activating interventions may support cancer prevention mechanisms. AMPK activation helps cells switch to efficient energy use and inhibits rapid, uncontrolled growth pathways associated with cancer.

Zinc deficiency is a widespread public health problem in low- and middle-income countries, with prevalence often exceeding 20% in various physiological groups, as measured by plasma zinc concentration.

In many low- and middle-income countries, zinc deficiency is a major public health issue affecting over 20% of the population in various groups. Public health efforts should prioritize screening and intervention, especially for women and children, using plasma zinc concentration as a key indicator.

Central nervous system (CNS) action of leptin and insulin is essential for maintaining body weight and fuel metabolism, with hypothalamic neurons (specifically POMC and AGRP/NPY populations) serving as primary mediators of their anorexigenic effects.

Your brain's ability to process signals from fat (leptin) and blood sugar (insulin) is the primary switch for hunger and energy use. In obesity, this switch gets stuck, making weight loss difficult despite high hormone levels. Restoring sensitivity to these signals is key to regulating energy homeostasis.

CNS insulin signaling regulates systemic glucose homeostasis primarily through POMC neurons, whereas its effect on body weight involves additional, less-defined neuronal populations.

Insulin's effect on blood sugar regulation is tightly linked to specific brain neurons (POMC), while its effect on weight involves a broader network. This explains why treating insulin resistance might improve blood sugar control differently than it affects body weight.

Obesity-induced CNS insulin and leptin resistance is driven by impaired blood-brain barrier transport, chronic low-grade inflammation (TNF-alpha, IL-6), and upregulation of negative regulators like SOCS3 and PTP1B.

In obesity, the brain stops listening to leptin and insulin due to inflammation and transport issues. This resistance is a key barrier to weight loss. Addressing inflammation and improving metabolic health may help restore the brain's ability to regulate weight.

Brown adipose tissue (BAT) activity in adult humans exhibits strong seasonal variation, with prevalence and intensity significantly higher in winter compared to summer, and this variation is more closely associated with photoperiod (night length) than ambient temperature.

Your body's fat-burning tissue (BAT) naturally fluctuates with the seasons, peaking in winter. This is driven more by day length than just cold exposure. Do not expect your metabolic rate to be identical year-round; however, this variation does not negate the importance of consistent healthy habits. If you are using cold exposure or other BAT-stimulating strategies, expect them to be more effective in colder months or shorter days.

Female adults have a significantly higher prevalence of brown adipose tissue (BAT) activity compared to male adults.

Women are more likely to have active brown fat than men. This biological difference may contribute to variations in metabolic rate and fat handling between sexes. It does not mean men cannot benefit from BAT activation, but the baseline prevalence is lower.

Breastfeeding is associated with beneficial effects in avoiding excess infant weight gain, childhood obesity, and higher blood pressure compared to formula feeding.

Encourage breastfeeding if possible, as it helps prevent excessive weight gain and obesity. If breastfeeding is not an option, focus on avoiding overfeeding with formula and delaying the introduction of solid foods until 6 months of age.

Maternal obesity and gestational diabetes significantly increase the risk of offspring obesity and type 2 diabetes, primarily through excess fetal adiposity and subsequent postnatal catch-up growth.

If you are obese or have gestational diabetes, be aware that your child is at higher risk for obesity and type 2 diabetes. Focus on healthy lifestyle choices for the whole family, including balanced diet and physical activity, and monitor your child's weight gain closely.

Mitochondrial dysfunction acts as a primary driver of skeletal muscle atrophy by triggering catabolic signaling pathways that promote the expression of muscle atrophy genes and increasing oxidative stress.

To support muscle mass, prioritize activities that improve mitochondrial health, such as regular aerobic and resistance exercise. These interventions help regulate mitochondrial function and may prevent or treat muscle atrophy, especially in aging or diseased states.

Premenopausal women exhibit higher insulin-stimulated glucose uptake in skeletal muscle compared to men, a difference mediated by estradiol signaling and higher adiponectin levels.

If you are a healthy premenopausal woman, your body is biologically wired to handle insulin and glucose more efficiently in your muscles than a man's, largely due to estrogen. This is a protective factor against type 2 diabetes, but it does not negate the importance of maintaining muscle mass and fitness.

Use of oral contraceptives (OC) containing ethinyl estradiol significantly reduces whole-body insulin sensitivity in young healthy women.

If you take birth control pills, be aware that the estrogen in them can make your body less sensitive to insulin by about 40% compared to women not on pills. This doesn't mean you will get diabetes, but it is a factor to consider if you have other risk factors.

Women have higher skeletal muscle lipoprotein lipase (mLPL) mRNA expression and higher plasma triglyceride clearance compared to men, facilitating greater lipid storage in muscle.

Women's bodies are biologically designed to clear fats from the blood into muscle more efficiently than men's. This is why women often have lower post-meal triglyceride levels, which is a protective factor for heart health.